Table 3.
Analysis of melanoma recurrence according to MMP-23 expression in the entire cohort and the subset of patients who received immunotherapy after primary resection
MMP-23 composite score | ||||
---|---|---|---|---|
Entire cohort a | Immunotherapy after primary resection b | |||
0 - 2 | 3 - 4 | 0 - 2 | 3 - 4 | |
Recurrence | ||||
Yes | 11 (59%) | 42 (81%) | 5 (46%) | 23 (79%) |
No | 8 (41%) | 10 (19%) | 6 (54%) | 6 (21%) |
Total | 19 (100%) | 52 (100%) | 11 (100%) | 29 (100%) |
aP = 0.067; bP = 0.056.